|
|
|
Volumn 9, Issue 1, 1999, Pages 79-95
|
|
Complications from induction regimens for thoracic malignancies: Perioperative considerations
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BLEOMYCIN;
CARBOPLATIN;
CISPLATIN;
CORTICOSTEROID;
CYCLOPHOSPHAMIDE;
ETOPOSIDE;
FLUOROURACIL;
IFOSFAMIDE;
MITOMYCIN;
NAVELBINE;
PACLITAXEL;
VINBLASTINE;
ADJUVANT CHEMOTHERAPY;
BONE MARROW SUPPRESSION;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RADIOTHERAPY;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
DIAGNOSTIC APPROACH ROUTE;
DISEASE ASSOCIATION;
DOSE TIME EFFECT RELATION;
DRUG INDUCED DISEASE;
HIGH RISK POPULATION;
HUMAN;
LUNG NON SMALL CELL CANCER;
MULTIMODALITY CANCER THERAPY;
PATHOGENESIS;
PEROPERATIVE CARE;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
RADIATION DOSE;
RADIATION PNEUMONIA;
REVIEW;
THORAX CANCER;
TREATMENT INDICATION;
ANTINEOPLASTIC AGENTS;
CARCINOMA, NON-SMALL-CELL LUNG;
FEMALE;
HUMANS;
LUNG DISEASES;
LUNG NEOPLASMS;
MALE;
NEOADJUVANT THERAPY;
POSTOPERATIVE CARE;
PREOPERATIVE CARE;
RADIATION INJURIES;
|
|
EID: 0033008306
PISSN: 10523359
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (22)
|
|
References (36)
|
